Shoulder Innovations Launches Next-Generation InSet® Glenoid Implant
Shoulder Innovations, Inc. (NYSE: SI) has initiated a limited user release of its next-generation InSet® Go glenoid implant for anatomic shoulder arthroplasty procedures. The first surgical case using the new device was performed by Dr. Robert Gillespie at University Hospitals Cleveland Medical Center. Developed over 20 years ago, the original InSet technology aimed to address glenoid loosening in shoulder replacements and has been refined with design improvements that preserve bone structure while simplifying surgery. The InSet Go reduces surgical steps and procedure time without compromising stability or clinical outcomes. It also includes new intellectual property protections for key components of its success, such as the articular surface and configurations addressing bone loss. Surgeons like Dr. Chris Chuinard have praised the implant's long-term stability and immediate fixation. Shoulder Innovations' CEO Rob Ball expressed optimism about market reception and plans to fully introduce InSet Go in upcoming quarters.
Tickers: $SI
Topics: healthcare innovation surgical_technology